ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 256927 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 256927; 2) Community: the network communities that were significantly associated with the response to NSC 256927; 3) Molecule: the relationships between components within communities and NSC 256927; 4) MDR: the compounds that were significantly associated with the NSC 256927.

NSC Compound Enrichment Correlation
NSC 693029 Null 0.0228801759885687 -0.12728565
NSC 701314 1H,3H-Thiazolo[3,4-a]benzimidazole, 1-(2,6-dichlorophenyl)-6-methoxy- 0.0228801759885687 0.2809538
NSC 710716 Null 0.0228801759885687 0.46718504
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0228801759885687 0.25216522
NSC 740 Methotrexate 0.0228801759885687 0.47231347
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0228801759885687 0.35408371
NSC 756404 GW843682X 0.0228801759885687 0.37857284
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0228801759885687 0.073015013
NSC 87364 Null 0.0228801759885687 0.44518742
NSC 126228 Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0238174255956147 0.3864324
Total:80  Current:36    [First] [Prev] [Next] [Last]